$1.31
0.000.00%
At close: -
$1.32
0.010.76%
After Hours: 4:19 PM EDT
Comments
Loading...
Cellectis Earnings Estimates, EPS & Revenue | NASDAQ:CLLS | Benzinga
Cellectis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS
$-0.160
Quarterly Revenue
$33.22M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$41.51M
Analyze the earnings history of Cellectis using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLLS | Cellectis | -$0.14 | — | — | — | $6.50M | — | — | — | 05/27/2025 | Get Alert |
| CLLS | Cellectis | -$0.57 | -$0.21 | -$0.16 | 23.81% | $1.99M | $9.17M | $33.22M | 262.22% | 03/13/2025 | Get Alert |
| CLLS | Cellectis | -$0.36 | -$0.21 | -$0.22 | -4.76% | $1.64M | $5.40M | $18.05M | 234.26% | 11/04/2024 | Get Alert |
| CLLS | Cellectis | -$0.15 | -$0.30 | -$0.27 | 10.00% | $2.00M | $3.47M | $9.50M | 173.89% | 08/06/2024 | Get Alert |
| CLLS | Cellectis | -$0.55 | -$0.33 | -$0.14 | 57.58% | $3.56M | $3.70M | $6.50M | 75.62% | 05/28/2024 | Get Alert |
| CLLS | Cellectis | -$0.57 | -$0.22 | -$0.57 | -159.09% | $17.32M | $16.26M | $1.99M | -87.76% | 04/29/2024 | Get Alert |
| CLLS | Cellectis | -$0.58 | -$0.42 | -$0.36 | 14.29% | $1.92M | $3.58M | $1.64M | -54.08% | 11/06/2023 | Get Alert |
| CLLS | Cellectis | -$0.36 | -$0.45 | -$0.15 | 66.67% | $2.77M | $4.48M | $2.00M | -55.31% | 08/03/2023 | Get Alert |
| CLLS | Cellectis | -$0.64 | -$0.48 | -$0.55 | -14.58% | $3.83M | $5.99M | $3.56M | -40.58% | 05/04/2023 | Get Alert |
| CLLS | Cellectis | -$0.48 | -$0.71 | -$0.57 | 19.72% | $13.66M | $13.92M | $17.32M | 24.44% | 03/08/2023 | Get Alert |
| CLLS | Cellectis | -$0.71 | -$0.45 | -$0.58 | -28.89% | $10.83M | $13.43M | $1.92M | -85.70% | 11/03/2022 | Get Alert |
| CLLS | Cellectis | -$0.80 | -$0.56 | -$0.36 | 35.71% | $14.62M | $11.27M | $2.77M | -75.47% | 08/04/2022 | Get Alert |
| CLLS | Cellectis | -$0.26 | — | -$0.64 | — | $27.97M | — | $3.83M | — | 05/12/2022 | Get Alert |
| CLLS | Cellectis | -$0.88 | -$0.92 | -$0.48 | 47.83% | $15.63M | $8.72M | $13.66M | 56.69% | 03/03/2022 | Get Alert |
| CLLS | Cellectis | -$0.63 | -$0.83 | -$0.71 | 14.46% | $9.24M | $11.14M | $10.83M | -2.81% | 11/04/2021 | Get Alert |
| CLLS | Cellectis | -$0.68 | -$0.73 | -$0.80 | -9.59% | $4.62M | $11.10M | $14.62M | 31.67% | 08/05/2021 | Get Alert |
| CLLS | Cellectis | $0.57 | -$0.81 | -$0.26 | 67.90% | $51.91M | $7.80M | $27.97M | 258.54% | 05/06/2021 | Get Alert |
| CLLS | Cellectis | -$0.73 | -$0.78 | -$0.88 | -12.82% | $6.34M | $7.64M | $15.63M | 104.61% | 03/04/2021 | Get Alert |
| CLLS | Cellectis | -$0.38 | -$0.61 | -$0.63 | -3.28% | $10.21M | $10.79M | $9.24M | -14.35% | 11/05/2020 | Get Alert |
| CLLS | Cellectis | -$0.65 | -$0.74 | -$0.68 | 8.11% | $2.93M | $5.01M | $4.62M | -7.86% | 08/05/2020 | Get Alert |
| CLLS | Cellectis | -$0.26 | -$0.64 | $0.57 | 189.06% | $3.43M | $16.23M | $51.91M | 219.82% | 05/06/2020 | Get Alert |
Cellectis (CLLS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.16 | $-0.21 | 23.8 % |
| Q3 | 2024-11-04 | $-0.22 | $-0.21 | -4.76 % |
| Q2 | 2024-08-06 | $-0.27 | $-0.30 | 10.0 % |
| Q1 | 2024-05-28 | $-0.14 | $-0.33 | 57.6 % |
Cellectis (CLLS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $33.22M | $9.17M | 262.2 % |
| Q3 | 2024-11-04 | $18.05M | $5.40M | 234.3 % |
| Q2 | 2024-08-06 | $9.50M | $3.47M | 173.9 % |
| Q1 | 2024-05-28 | $6.50M | $3.70M | 75.6 % |
FAQ
When is Cellectis (NASDAQ:CLLS) reporting earnings?
Cellectis (CLLS) is scheduled to report earnings on May 27, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Cellectis (NASDAQ:CLLS)?
The Actual EPS was $-0.16, which beat the estimate of $-0.21.
What were Cellectis’s (NASDAQ:CLLS) revenues?
The Actual Revenue was $33.2M, which beat the estimate of $9.2M.
Browse earnings estimates, EPS, and revenue on all stocks.